536-17-4

Applied Filters:

Keyword:'536-17-4'

Showing 1-2 of 2 results for "536-17-4" within Papers

An immunoprotective privilege of corneal epithelial stem cells against Th17 inflammatory stress by producing glial cell-derived neurotrophic factor.

Fang Bian et al.

Stem cells (Dayton, Ohio), 28(12), 2172-2181 (2010-10-12)

Adult stem cells are well known for their self-renewal and regenerative capacity. The mechanisms protecting these cells from inflammatory damage have not been well elucidated. This study investigated the immunoprotective properties of corneal epithelial stem cells from inflammation by producing

Thalidomide before and after autologous stem cell transplantation in recently diagnosed multiple myeloma (HOVON-50): long-term results from the phase 3, randomised controlled trial.

Niels Wcj van de Donk et al.

The Lancet. Haematology, 5(10), e479-e492 (2018-10-07)

In patients with recently diagnosed multiple myeloma, the HOVON-50 phase 3 trial showed improved event-free survival for thalidomide-containing induction and maintenance regimens (in conjunction with high-dose melphalan and autologous stem cell transplantation [auto-SCT]) after a median of 52 months of

Page 1 of 1